BIOMARKERS OF IMMUNE TOLERANCE IN LIVER TRANSPLANTATION

Author:

Shevchenko O. P.1,Kurabekova R. M.2,Tsiroulnikova O. M.1

Affiliation:

1. V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow; I.M. Sechenov Fist Moscow State Medical University, Moscow

2. V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow

Abstract

This review of literature is dedicated to the analysis of the current studies of biomarkers, which could help predict immune tolerance development and identify the patients, who can safely minimize immunosuppression after liver transplantation. The review analyzed 46 sources of literature, more than half of those were published in the last fi ve years. Up to date advanced technologies are intensively developed, which help understand molecular mechanisms of normal, pathological and pharmacological processes involved in organ transplantations. However, there are no biomarkers yet validated for the identifi cation of immune tolerance development or individual prescription of immunosuppressants. Further data collection on patients along with the progress in bioinformatics could accelerate development of approaches for patient stratifi cation. 

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference46 articles.

1. Adams DH, Sanchez-Fueyo A, Samuel D. From immunosuppression to tolerance. J. Hepatol. 2015; 62: 170–185.

2. Got'e SV. Transplantologiya: itogi i perspektivy. Tom VI. 2014 god. M.–Tver': Triada; 2015. 448 s. Gautier SV. Transplantologiya: itogi i perspectivy. Tom VI. 2014 god. M.–Tver: Triada; 2015. 448. [In Russian]

3. Marcen R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009; 69 (16): 2227–2243.

4. Ekberg H, Bernasconi C, Noldeke J, Yussim A, Mjornstedt L, Erken U et al. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profi les despite low doses in the Symphony study. Nephrol. Dial. Transplant. 2010; 25 (6): 2004–2010.

5. Heidt S, Wood KJ. Biomarkers of Operational Tolerance in Solid Organ Transplantation. Expert Opin. Med. Diagn. 2012; 6 (4): 281–293.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Equivalents of the neutrophil-to-lymphocyte ratio of circulating pool of stem and immature hematopoietic cells for assessing liver transplant status;Russian Journal of Transplantology and Artificial Organs;2023-06-20

2. Renal replacement therapy in heart transplant recipients;Russian Journal of Transplantology and Artificial Organs;2021-10-22

3. Tolerance and minimization of immunosuppressive therapy after liver transplantation;Russian Journal of Transplantology and Artificial Organs;2021-09-16

4. Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation;Bulletin of Experimental Biology and Medicine;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3